Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-16

FDA Approved: TADALAFIL — Supplemental Application (AvKARE)

View source ↗

Summary

FDA supplemental approval for tadalafil from AvKARE (ANDA210608).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

SUPPL AP for TADALAFIL (TADALAFIL)